Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical In Vitro Observations
George J. Kahaly, Lisa A. Steiner, Miranda M.C. van der Lee, Tanja A.E. van Achterberg et autres
Background:Treatment of Graves' hyperthyroidism (GH) and Graves' orbitopathy (GO) is far from adequate, and hence, new substances that specifically target the autoantigens in GH/GO are warranted. This study determined the preclinical in vitro efficacy of SYD5115, a novel low-molecular-weight compound that inhibits …
de (code pays fourni par la source)